A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

Clinical trial NCT07664735 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07664735
Sponsor: Outpace Bio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer Recurrent Endometrial Cancer Advanced Endometrial Cancer Ovarian Cancer Ovarian Cancer Recurrent Platinum Resistant Ovarian Cancer Endometrial Cancers

Start date: 2026-06-30
Primary completion: 2030-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.